Press release
Tissue Engineering Market Expected to Reach US$ 64.17 Billion by 2033 Driven by Advancements in Regenerative Medicine | Key Players:- Lonza Group, InSphero AG, Merck KGaA
Tissue engineering market 2026-2033
The global Tissue Engineering Market was valued at US$ 18.9 billion in 2024 and is projected to reach US$ 64.17 billion by 2033, expanding at a CAGR of 14.9% during the forecast period (2025-2033).
Tissue engineering is gaining significant traction as healthcare systems increasingly focus on regenerative solutions capable of repairing or replacing damaged tissues and organs. The growing burden of chronic diseases, traumatic injuries, and organ failure is accelerating the adoption of engineered tissues in both clinical and research applications.
Market interest is also expanding due to rapid technological progress in regenerative medicine, stem cell therapy, and 3D bioprinting. These innovations are enabling the development of artificial tissues and organ substitutes, creating new opportunities for therapeutic treatments and biomedical research.
In addition, rising healthcare investments, increasing research funding, and the growing demand for personalized medicine are positioning tissue engineering as a promising long-term investment area within the biotechnology and healthcare sectors.
Download your executive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/tissue-engineering-market?prtk
Key Industry Developments
United States
✅ June 2025: Medtronic received FDA Breakthrough Device Designation for its Infuse bone graft combined with an intervertebral fusion device. The designation accelerates the development of regenerative bone repair technologies and supports commercialization of tissue-engineering-based spinal fusion solutions.
✅ April 2025: Abbott Laboratories secured regulatory approval for its Esprit BTK bioresorbable scaffold, designed to restore blood flow in below-the-knee arteries. The scaffold gradually dissolves after supporting vessel healing, representing an advancement in vascular tissue engineering.
✅ February 2025: Humacyte initiated the commercial launch of its Symvess bioengineered human tissue vessel in the United States following regulatory clearance. Early shipments were delivered to trauma centers, marking a major step toward commercial availability of lab-engineered implantable tissues.
Asia Pacific - Japan
✅ April 2025: Japan Tissue Engineering Co., Ltd. launched a contract testing service using LabCyte cultured tissue models for skin sensitization testing without animal experimentation. The initiative expands the application of regenerative tissue models in pharmaceutical and cosmetic research.
✅ March 2025: Japan Tissue Engineering Co., Ltd. strengthened collaboration with Teijin Limited's structural analysis division to enhance regenerative medicine research and improve manufacturing efficiency for cultured tissue products.
✅ January 2025: Japan expanded national regenerative medicine initiatives supporting iPS cell and organoid-based tissue engineering technologies, encouraging research collaborations aimed at scalable production of cultured tissues for drug testing and clinical use.
Market Drivers
Rising Prevalence of Chronic and Degenerative Diseases
In both the United States and Japan, the increasing incidence of cardiovascular diseases, diabetes, and osteoarthritis is creating demand for regenerative therapies capable of repairing or replacing damaged tissues.
Growing Aging Population
Japan has one of the world's most rapidly aging populations, while the United States is also experiencing steady growth in elderly demographics. This trend is increasing demand for tissue-engineered skin, bone, and cartilage products used in treating age-related tissue degeneration.
Advancements in Stem Cell and Biomaterials Research
Strong research investment in both countries is accelerating innovations in stem cell technologies, biomaterial scaffolds, and 3D bioprinting, enabling the development of functional tissue substitutes.
Demand for Alternatives to Organ Transplants
The global shortage of donor organs continues to push healthcare systems to explore tissue engineering technologies capable of generating lab-grown tissues and organs.
Government Support for Regenerative Medicine
Government funding programs and supportive regulatory frameworks in the United States and Japan are encouraging innovation and accelerating the commercialization of tissue engineering therapies.
Strategic Mergers and Acquisitions
December 2025: Solventum acquired Acera Surgical for approximately US$ 850 million, strengthening its position in regenerative wound care and synthetic tissue matrix technologies.
December 2025: LifeNet Health acquired Tissue Testing Technologies (T3) to enhance its regenerative medicine and tissue preservation capabilities.
August 2025: LifeNet Health expanded its global regenerative medicine footprint through the acquisition of HCM Medical, strengthening its biologics processing and tissue engineering capabilities.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/tissue-engineering-market?prtk
Major Players:-
3D BioFibR Inc. | CollPlant Biotechnologies Ltd | Lonza Group | InSphero AG | Merck KGaA | Thermo Fisher Scientific Inc. | Corning Incorporated | Prellis Biologics | Collagen Solutions (US) LLC | SunP BIOTECH | Cellink
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific holds approximately 6% share within the tissue engineering ecosystem. Its leadership is supported by an extensive portfolio of cell culture media, reagents, and 3D cell culture technologies, including the widely used Gibco platform.
Merck KGaA
Merck KGaA commands roughly 4.5% market share through its MilliporeSigma division, which offers advanced biomaterials, cell culture technologies, and life-science reagents used in regenerative medicine research.
Lonza Group
Lonza Group holds around 4% share, driven by expertise in cell therapy manufacturing, culture media development, and contract biomanufacturing services supporting tissue engineering innovations.
Corning Incorporated
Corning accounts for approximately 3% share of the tissue engineering research tools segment. Its cell culture surfaces and scaffolds support advanced 3D cell growth and tissue modeling.
CollPlant Biotechnologies Ltd
CollPlant holds an estimated 2% niche share and specializes in recombinant human collagen produced through plant-based technology, widely used in 3D bioprinting and regenerative scaffolds.
Market Segmentation Analysis
By Product Type
Scaffolds represent the largest segment with 46% market share in the United States and Japan in 2024, as they provide structural support for cell attachment and tissue regeneration.
Biomaterials account for 32%, driven by collagen- and polymer-based matrices used in implants and wound healing. Cells and growth factors represent 22%, reflecting expanding research in regenerative therapies.
By Material Type
Synthetic materials lead the market with 54% share, supported by the widespread use of polymers such as PLA, PGA, and PLGA due to their durability and controlled degradation.
Natural biomaterials account for 46%, driven by increasing use of collagen, fibrin, and hyaluronic acid in regenerative therapies.
By Application
Orthopedic applications dominate with 34% share, driven by rising cases of fractures, osteoarthritis, and sports injuries.
Skin and integumentary applications account for 27%, followed by cardiovascular applications (17%), neurology (12%), and other applications (10%).
By End User
Hospitals and clinics represent the largest segment with 52% share, as regenerative procedures are primarily conducted in specialized healthcare centers.
Research institutes account for 31%, while biotechnology and pharmaceutical companies hold 17%, focusing on commercialization of tissue-engineered products.
Regional insights:-
North America - 42%
North America leads the global market due to strong R&D funding, extensive clinical trials, and a highly developed regenerative medicine ecosystem in the United States.
Europe - 28%
Europe holds the second-largest share, supported by strong biomedical research programs and regulatory support in countries such as Germany, the United Kingdom, and France.
Asia Pacific - 22%
Asia Pacific is the fastest-growing region, driven by significant investments in biotechnology and regenerative medicine, particularly in Japan, China, and South Korea.
Latin America - 4%
Latin America represents an emerging market supported by improving healthcare infrastructure and rising awareness of regenerative therapies.
Middle East & Africa - 4%
The region is gradually expanding due to improving healthcare access and increasing adoption of advanced medical technologies.
Why This Report Matters for Industry Stakeholders
This report provides:
✔ Detailed market size and growth forecasts
✔ Comprehensive competitive landscape analysis
✔ Technology roadmap and innovation trends
✔ Insights into strategic mergers, partnerships, and investments
✔ Regional demand analysis and future growth opportunities
📈 Secure your 30% Discount on the Full Report:
https://www.datamintelligence.com/buy-now-page?report=tissue-engineering-market?prtk
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tissue Engineering Market Expected to Reach US$ 64.17 Billion by 2033 Driven by Advancements in Regenerative Medicine | Key Players:- Lonza Group, InSphero AG, Merck KGaA here
News-ID: 4418416 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Radiation-Protection Apparels Market Expected to Reach US$2.86 Billion by 2032, …
The global Radiation-Protection Apparels market reached US$1.42 billion in 2024 and is expected to reach US$2.86 billion by 2032, expanding at a CAGR of 8.6% during the forecast period 2025-2032.
The radiation-protection apparel market is witnessing steady growth due to the increasing use of diagnostic imaging and radiation-based procedures in healthcare settings. Radiation-protection apparel, such as lead aprons, thyroid shields, gloves, and protective eyewear, is widely used by medical professionals to…
Cleanroom Consumables Market Expected to Reach US$18.66 Billion by 2033, Growing …
The global Cleanroom Consumables market reached US$10.8 billion in 2024 and is expected to reach US$18.66 billion by 2033, expanding at a CAGR of 6.5% during the forecast period 2025-2033.
The cleanroom consumables market is experiencing steady growth due to the increasing demand for contamination control in industries such as pharmaceuticals, biotechnology, medical devices, and semiconductor manufacturing. Cleanroom consumables include products such as gloves, wipes, apparel, face masks, and cleaning supplies…
Memory Chip Market Trends, Innovations & Growth Insights | Latest Technology & I …
DataM Intelligence has published a new research report on "Memory Chip Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Download Updated Sample PDF Report (Get Higher Priority…
Smart Packaging Market Expected to Reach US$49.23 Billion by 2032, Growing at a …
The global Smart Packaging market reached US$29.12 billion in 2024 and is expected to reach US$49.23 billion by 2032, expanding at a CAGR of 10.6% during the forecast period 2025-2032.
The smart packaging market is witnessing steady growth due to increasing demand for advanced packaging solutions that enhance product safety, quality monitoring, and consumer engagement. Smart packaging integrates technologies such as sensors, RFID tags, QR codes, and temperature indicators to provide…
More Releases for Tissue
Tissue Paper Market: Unraveling the Sustainability and Versatility of Tissue Pro …
Exploring the Mysteries of the Tissue Paper Market: A Comprehensive Market Research Report
Discover the intricate tapestry of the "Tissue Paper Market" through our latest market intelligence opus. This comprehensive report delves deep into the heart of this mystical realm, offering an immersive journey through descriptive data and insightful visuals that illuminate both local nuances and global trends. Uncover the essence of leading competitors, their market value treasures, evolving strategies,…
Tissue Towel Market Report 2021: COVID-19 Growth And Change Players are Cascades …
The Tissue Towel Market is rising at a sooner tempo with considerable development charges over the previous couple of years and is estimated that the market will develop considerably within the forecasted period.
Looking for More Insights from this Report? Get Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-tissue-towel-market&utm_source=manisha
(The sample of this report is readily available on request)
This Free report sample includes:
• A brief introduction to the research report.
• Graphical introduction of the regional…
Printed Tissue Paper Market 2020 Strategic Assessment - Royal Tissue Products., …
Printed Tissue Paper Market In-depth Analysis 2020-2027
The Printed Tissue Paper Market provides a 360 view and insights, outlining the key outcomes of the industry, current scenario witnesses a slowdown and study aims to unique strategies followed by key players. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. The study bridges the historical data from 2014 to 2020 and estimated till 2027*. Some…
Industry Update: Printed Tissue Paper Market Set New Growth Story | Royal Tissue …
Printed Tissue Paper Market will reach an estimated valuation of USD 651.2 million by 2027, while registering this growth at a rate of 4.80% for the forecast period of 2020 to 2027. FMCG Industry is facing Challenges to adapt to new Delivery and Purchasing Pattern to Ride out the Covid19 Disruption
Increasing knowledge concerning sanitation and healthcare is a principal constituent stimulating the market for tissue paper. Furthermore, practice of tissue…
Roll Towel Tissue Towel Market 2018 Organized Authoritative Study report By WEPA …
Fior Markets offers a latest published report on Global Roll Towel Tissue Towel Market Growth 2018-2023, providing key insights and giving a competitive advantage to consumers through a detailed report. The researchers have included essential figures associated with the production and consumption forecast for the major regions that the market is separated into consumption forecast by application and production forecast by type. The research study is a source of methodical…
Tissue Expanders Market Global Review 2017 to 2026| by Region - North America, L …
According to Fact.MR, the global tissue expanders market is expected to represent a value of over US$ 800 Mn by the end of 2026.
Removal of breast attributed to growing cases of breast cancer has led to surge in demand for reconstructing breast. In addition, increasing demand for reconstructing the scalp and forehead skin attributed to skin distinction is expected to contribute towards growth of the global tissue expanders market during…
